Clinical Trial Update: Fluorescein vs. iMRI in Resection of Malignant High Grade Glioma [NA]

View source ↗

Summary

The clinical trial NCT02540135 evaluating fluorescein-guided resection with intraoperative MRI for malignant high-grade gliomas has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Glioblastoma

Drugs mentioned

• Fluorescein Sodium (fluorescein sodium)

Snippet

Sponsor: University of Colorado, Denver | Conditions: High Grade Malignant Neoplasm, Glioblastoma Multiforme | NA | Status: WITHDRAWN